Rising Public Expenditure Favoring Brazilian Pharma Growth
According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", Brazil is among the few countries in the world to have a universal and free public health-care system. The taxes paid by Brazilians cover all kinds of services and treatments offered by the National Health System (System UNICCO de Saudi, SUS), without charging any additional amounts to the user. SUS's share of industry expenditures, which include Federal, State and Municipal governments, has grown from 41.7% in...
View full press release